1. Home
  2. BGNE vs CLX Comparison

BGNE vs CLX Comparison

Compare BGNE & CLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGNE
  • CLX
  • Stock Information
  • Founded
  • BGNE 2010
  • CLX 1913
  • Country
  • BGNE Cayman Islands
  • CLX United States
  • Employees
  • BGNE N/A
  • CLX N/A
  • Industry
  • BGNE Biotechnology: Pharmaceutical Preparations
  • CLX Specialty Chemicals
  • Sector
  • BGNE Health Care
  • CLX Consumer Discretionary
  • Exchange
  • BGNE Nasdaq
  • CLX Nasdaq
  • Market Cap
  • BGNE 19.2B
  • CLX 20.9B
  • IPO Year
  • BGNE 2016
  • CLX N/A
  • Fundamental
  • Price
  • BGNE $175.87
  • CLX $161.70
  • Analyst Decision
  • BGNE Buy
  • CLX Hold
  • Analyst Count
  • BGNE 8
  • CLX 13
  • Target Price
  • BGNE $253.69
  • CLX $155.38
  • AVG Volume (30 Days)
  • BGNE 476.1K
  • CLX 1.1M
  • Earning Date
  • BGNE 11-12-2024
  • CLX 01-30-2025
  • Dividend Yield
  • BGNE N/A
  • CLX 3.00%
  • EPS Growth
  • BGNE N/A
  • CLX 316.16
  • EPS
  • BGNE N/A
  • CLX 2.88
  • Revenue
  • BGNE $3,351,304,621.00
  • CLX $7,469,000,000.00
  • Revenue This Year
  • BGNE $969.39
  • CLX $0.49
  • Revenue Next Year
  • BGNE $24.79
  • CLX $2.43
  • P/E Ratio
  • BGNE N/A
  • CLX $56.23
  • Revenue Growth
  • BGNE 50.22
  • CLX 6.17
  • 52 Week Low
  • BGNE $126.97
  • CLX $127.60
  • 52 Week High
  • BGNE $248.16
  • CLX $171.37
  • Technical
  • Relative Strength Index (RSI)
  • BGNE 34.52
  • CLX 36.42
  • Support Level
  • BGNE $174.50
  • CLX $163.88
  • Resistance Level
  • BGNE $180.00
  • CLX $166.35
  • Average True Range (ATR)
  • BGNE 6.73
  • CLX 2.75
  • MACD
  • BGNE -2.17
  • CLX -0.80
  • Stochastic Oscillator
  • BGNE 3.24
  • CLX 10.58

About BGNE BeiGene Ltd.

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

About CLX Clorox Company (The)

Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.

Share on Social Networks: